Relationships between medication treatments and neuropsychological test performance in schizophrenia.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Psychiatry Research

• Publication date

  1991-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/0165-1781(91)90065-WPMID 1679950
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Contributions of clinical neuropsychology to the study of schizophrenia.

  1989cited by this paper
• Cognitive impairments associated with early Parkinson's disease

  1989cited by this paper
• Defective concept formation in parkinsonians is independent from mental deterioration.

  1989cited by this paper
• Insight and the Clinical Outcome of Schizopheric Patients

  1989cited by this paper
• Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia.

  1989cited by this paper
• The effect of neuroleptics on dysfunction in a prefrontal substrate of sustained attention in schizophrenia.

  1988cited by this paper
• Cognitive impairment in schizophrenia: specific relations to ventricular size and negative symptomatology.

  1988cited by this paper
• Induction of cortical cholinergic hypofunction and memory retention deficits through intracortical AF64A infusions.

  1988cited by this paper
• Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. IV. Further evidence for regional and behavioral specificity.

  1988cited by this paper
• Memory deficits and anticholinergic levels in chronic schizophrenia.

  1986cited by this paper
• Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow.

  1986cited by this paper
• Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence.

  1986cited by this paper
• Psychopharmacologic and clinical correlates of attention in chronic schizophrenia.

  1985cited by this paper
• Chemotherapy in psychiatry : principles and practice

  1985cited by this paper
• Schizophrenia and brain dysfunction: an integration of recent neurodiagnostic findings

  1983cited by this paper
• Spatial working memory in rats: effects of monoaminergic antagonists.

  1983cited by this paper
• The Withdrawal of Benztropine Mesylate in Chronic Schizophrenic Patients

  1983cited by this paper
• Central catecholamine metabolism in vivo and the cognitive and motor deficits in Parkinson's disease.

  1983cited by this paper
• Schizophrenia and brain dysfunction: an integration of recent neurodiagnostic findings.

  1983cited by this paper
• The cholinergic hypothesis of geriatric memory dysfunction.

  1982cited by this paper
• Serum levels of anticholinergic drugs and impaired recent memory in chronic schizophrenic patients.

  1982cited by this paper
• Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey.

  1979cited by this paper
• Cognitive concomitants of hemispheric dysfunction in schizophrenia.

  1979cited by this paper
• The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance.

  1976cited by this paper
• Schizophrenic performance when distractors are present: attentional deficit or differential task difficulty?

  1975cited by this paper
• THE EFFECTS OF DRUGS ON PSYCHIATRIC PATIENTS' PERFORMANCE ON THE HALSTEAD‐REITAN NEUROPSYCHOLOGICAL TEST BATTERY

  1975cited by this paper
• NEUROPSYCHOLOGICAL, PATTERNS IN CHRONIC SCHIZOPHRENIA

  1970cited by this paper
• Perceptual acuity and sympathetic reactivity in schizophrenia.

  1963cited by this paper
• THE PSYCHOPHARMACOLOGY OF PHENOTHIAZINE COMPOUNDS: A COMPARATIVE STUDY OF THE EFFECTS OF CHLORPROMAZINE, PROMETHAZINE, TRIFLUOPERAZINE, AND PERPHENAZINE IN NORMAL MALES. II

  1963cited by this paper
• Phenothiazine effects in chronic schizophrenia.

  1962cited by this paper
• The Brief Psychiatric Rating Scale

  1962cited by this paper
• The Quick Test (QT): Provisional Manual 1 , 2

  1962cited by this paper
• Maze test reactions after chlorpromazine.

  1957cited by this paper

• Anticholinergic Burden and Cognitive Function in Psychosis: A Systematic Review and Meta-Analysis.

  2025cites this paper
• Cognitive impairment in the schizophrenia spectrum: exploring the relationships of the g-factor with sociodemography, psychopathology, neurodevelopment, and genetics

  2024cites this paper
• Place of the partial dopamine receptor agonist aripiprazole in the management of schizophrenia in adults: a Delphi consensus study

  2022cites this paper
• Less is more: Deprescribing anticholinergic medications in persons with severe mental illness.

  2021cites this paper
• Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disorders

  2021cites this paper
• Less is more: Deprescribing anticholinergic medications in persons with severe mental illness.

  2021cites this paper
• Protocol of guided antipsychotic reduction to reach minimum effective dose (GARMED) in patients with remitted psychosis based on pragmatic design

  2021cites this paper
• Impact of polygenic risk for coronary artery disease and cardiovascular medication burden on cognitive impairment in psychotic disorders.

  2021cites this paper
• The effects of antipsychotic and antiparkinsonian medication on psychosocial skill learning

  2021cites this paper
• Anticholinergic Burden and Cognitive Performance in Patients With Schizophrenia: A Systematic Literature Review

  2021cites this paper
• Neuropsychological deficits correlate with symptoms severity and cortical thickness in Borderline Personality Disorder.

  2020cites this paper
• Widespread white-matter microstructure integrity reduction in first-episode schizophrenia patients after acute antipsychotic treatment.

  2019cites this paper
• A Meta-Analysis of Relationships between Measures of Wisconsin Card Sorting and Intelligence

  2019cites this paper
• Characteristics of Medicaid Recipients Receiving Persistent Antipsychotic Polypharmacy

  2018cites this paper
• THE RELATIONSHIP OF COGNITIVE FUNCTION TO OUTCOME

  2018cites this paper
• Cognitive burden of anticholinergic medications in psychotic disorders.

  2017influential citation
• Deviation from expected cognitive ability across psychotic disorders.

  2017cites this paper
• The Cholinergic System: An Emerging Drug Target for Schizophrenia.

  2016cites this paper
• Pharmacokinetic patterns of risperidone-associated adverse drug reactions

  2016cites this paper
• Assessing the Relationship between Semantic Processing and Thought Disorder Symptoms in Schizophrenia

  2015cites this paper
• Impact of antipsychotic treatment on attention and motor learning systems in first-episode schizophrenia.

  2015cites this paper
• Antipsychotic Medications: Linking Receptor Antagonism to Neuropsychological Functioning in First Episode Psychosis

  2012cites this paper
• Safety and tolerability of antipsychotic polypharmacy

  2012cites this paper
• The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients.

  2012cites this paper
• Prefrontal gray matter morphology mediates the association between serum anticholinergicity and cognitive functioning in early course schizophrenia.

  2012cites this paper
• Demographic And Clinical Factors Associated With Verbal Memory Performance In Patients With Schizophrenia In Hospital Universiti Sains Malaysia (HUSM), Malaysia

  2011cites this paper
• Clinical significance of neurological soft signs in schizophrenia: factor analysis of the Neurological Evaluation Scale.

  2010cites this paper
• Effects of word frequency on semantic memory in schizophrenia: electrophysiological evidence for a deficit in linguistic access.

  2010cites this paper
• Antipsychotic medications: linking receptor antagonist properties to neuropsychological functioning

  2010cites this paper
• Nonstimulant Psychotropic Medication: Desired and Adverse Cognitive Events

  2009cites this paper
• Executive Functioning in Schizophrenia: The Contributions of Attention, Working Memory, Processing Speed

  2008cites this paper
• Cognitive improvement in response to antipsychotic drugs: neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.

  2007cites this paper
• Methods for treating cognitive deficits in schizophrenia

  2007cites this paper
• Sustained attention and executive functions in euthymic young people with bipolar disorder.

  2006cites this paper
• Switching Patients with Chronic Schizophrenia to Aripiprazole : the Improvement in Cognitive Function

  2006cites this paper
• The Other Side of Psychopharmacology: A Review of the Literature

  2006cites this paper
• Regional brain metabolism as the predictor of performance on the Trail Making Test in schizophrenia. A 18FDG PET covariation study.

  2006cites this paper
• Switching antipsychotics: an updated review with a focus on quetiapine

  2006cites this paper
• Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trial.

  2006cites this paper
• The impact of atypical antipsychotic medications on long-term memory dysfunction in schizophrenia spectrum disorder: a quantitative review

  2006cites this paper
• Impairments of executive/attentional functions in schizophrenia with primary and secondary negative symptoms.

  2005cites this paper
• The Role of Attention in Affect Perception : An Examination of Mir sky ' s Four Factor Model of Attention in Chronic Schizophrenia

  2005cites this paper
• A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.

  2005cites this paper
• Neurocognition and functional outcome : Individual factors Novel Antipsychotic Medications Anticholinergic Medications Conventional Antipsychotic Medications Neurocognition Functional Outcome Psychotic Symptoms Negative Symptoms

  2005cites this paper
• Verbal memory, problem-solving skills and community status in schizophrenia.

  2004cites this paper
• Do schizophrenia patients make more perseverative than non-perseverative errors on the Wisconsin Card Sorting Test? A meta-analytic study.

  2004cites this paper
• Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.

  2004cites this paper
• The use of antiparkinsonian agents in the management of drug-induced extrapyramidal symptoms.

  2004cites this paper
• Correlation between scores on Continuous Performance Test and plasma concentration for schizophrenic patients on risperidone

  2004cites this paper
• Impairment of verbal memory and learning in antipsychotic-naïve patients with first-episode schizophrenia.

  2004cites this paper
• Dosisabhängigkeit subjektiver kognitiver Dysfunktionen unter atypischen versus konventionellen Neuroleptika

  2004cites this paper
• Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol.

  2004cites this paper
• A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book.

  2004cites this paper
• The Role of Attention in Affect Perception: An Examination of Mirsky's Four Factor Model of Attention in Chronic Schizophrenia

  2004cites this paper
• The Impact of Age of Onset and Effects of Antipsychotics on Executive Functions, Attention, and Reaction Time: A Study of Cognitive Functions in First-Episode Psychotic Children and Schizophrenic Adults

  2004cites this paper
• Intellectual functioning in schizophrenia: a marker of neurodevelopmental damage?

  2004cites this paper
• Effects of Low-Dose Risperidone and Low-Dose Zuclopenthixol on Cognitive Functions in First-Episode Drug-Naïve Schizophrenic Patients

  2004cites this paper
• Bestimmung dosiskorrelierter subjektiver neurokognitiver Dysfunktionen nach Gabe konventioneller oder atypischer Neuroleptika

  2003cites this paper
• Reliable Change Indexes for Memory Performance in Schizophrenia as a Means to Determine Drug-Induced Cognitive Decline

  2003cites this paper
• The relationship between gonadal hormones and neurocognitive functioning in healthy men and women and patients with schizophrenia

  2003cites this paper
• Effects of Anticholinergic Drug Withdrawal on Memory, Regional Cerebral Blood Flow and Extrapyramidal Side Effects in Schizophrenic Patients

  2002cites this paper
• Executive Control Function in Psychiatric and Medical Illness

  2002cites this paper
• Rigidity of thought and behavior: 100 years of research.

  2002cites this paper
• Relationship between neuroleptic dosage and subjective cognitive dysfunction in schizophrenic patients treated with either conventional or atypical neuroleptic medication

  2002influential citation
• Effects of anticholinergic drug withdrawal on memory, regional cerebral blood flow and extrapyramidal side effects in schizophrenic patients.

  2002cites this paper
• Implicit and explicit learning in schizophrenics treated with olanzapine and with classic neuroleptics

  2002cites this paper
• An analysis of the specificity and the syndromal correlates of verbal memory impairments in schizophrenia.

  2001cites this paper
• Translating the basic and clinical cognitive neuroscience of schizophrenia to drug development and clinical trials of antipsychotic medications.

  2001cites this paper
• Memory and attention deficits in drug naive patients with schizophrenia.

  2001cites this paper
• Studies of cerebral laterality in early onset schizophrenia

  2001cites this paper
• Relationship between Subjective Cognitive Symptoms and Frontal Executive Abilities in Chronic Schizophrenic Outpatients

  2001cites this paper
• Clozapine Enhances Neurocognition and Clinical Symptomatology More Than Standard Neuroleptics

  2001cites this paper
• A preliminary study of the comparative effects of olanzapine and fluphenazine on cognition in schizophrenic patients

  2000cites this paper
• Semantic verbal fluency deficit as a familial trait marker in schizophrenia.

  2000cites this paper
• Cognitive Dysfunctions in Bipolar Disorder: Evidence of Neuropsychological Disturbances

  1999cites this paper
• Executive functioning and verbal memory in young patients with unipolar depression and schizophrenia.

  1999cites this paper
• Cognitive effects of conventional and atypical antipsychotics in schizophrenia

  1999cites this paper
• Independent frontal-system deficits in schizophrenia: cognitive, clinical, and adaptive implications.

  1999cites this paper
• The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis.

  1999cites this paper
• Should schizophrenia be treated as a neurocognitive disorder

  1999cites this paper
• Should schizophrenia be treated as a neurocognitive disorder?

  1999cites this paper
• The Cognitive Efficacy of Atypical Antipsychotics in Schizophrenia

  1998cites this paper
• A review of neuropsychological differences between paranoid and nonparanoid schizophrenia patients.

  1998cites this paper
• Nonstimulant Psychotropic Medication

  1997cites this paper
• Non-selective impairment of Wisconsin Card Sorting Test performance in patients with schizophrenia.

  1997cites this paper
• Does risperidone improve verbal working memory in treatment-resistant schizophrenia?

  1997cites this paper
• Der Beitrag der Neuropsychologie zur Psychiatrie

  1996cites this paper
• Effects of antipsychotic drugs on neuropsychological measures

  1996cites this paper
• [Quantitative EEG, basic disorders and smoking in etiopathogenetically different groups of paranoid-hallucinatory psychoses--an exploratory study].

  1995cites this paper
• The Effects of Antipsychotic and Antiparkinsonian Medication on Psychosocial Skill Learning

  1995cites this paper
• An assessment of the Wisconsin Card Sorting Test as an indicator of liability to schizophrenia.

  1994cites this paper
• Memory function in schizophrenia

  1994cites this paper
• Cognitive disorders and negative symptoms as correlates of motivational deficits in psychotic patients

  1994cites this paper
• The Wisconsin Card Sorting Test discriminates schizophrenic patients and their siblings.

  1993cites this paper
• Neurodynamics of abnormalities in cerebral metabolism and structure in schizophrenia.

  1993cites this paper
• Neuropsychological and eye movement abnormalities in first-episode and chronic schizophrenia.

  1992cites this paper
• Evaluation of the stability of neuropsychological functioning after acute episodes of schizophrenia: one-year followup study.

  1991cites this paper